1. Home
  2. BZH vs REPL Comparison

BZH vs REPL Comparison

Compare BZH & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$22.54

Market Cap

717.3M

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$10.27

Market Cap

721.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZH
REPL
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
717.3M
721.7M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
BZH
REPL
Price
$22.54
$10.27
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$32.00
$12.00
AVG Volume (30 Days)
504.8K
1.7M
Earning Date
01-29-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.52
N/A
Revenue
$2,371,555,000.00
N/A
Revenue This Year
$7.40
N/A
Revenue Next Year
$12.09
N/A
P/E Ratio
$14.82
N/A
Revenue Growth
1.77
N/A
52 Week Low
$17.37
$2.68
52 Week High
$32.21
$14.80

Technical Indicators

Market Signals
Indicator
BZH
REPL
Relative Strength Index (RSI) 51.90 61.36
Support Level $21.50 $9.35
Resistance Level $23.21 $11.09
Average True Range (ATR) 0.80 0.60
MACD 0.09 -0.08
Stochastic Oscillator 60.56 53.32

Price Performance

Historical Comparison
BZH
REPL

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: